Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$821M |
| 2 |
AGN
Allergan plc
AGN
|
+$444M |
| 3 |
Apple
AAPL
|
+$304M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$301M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$839M |
| 2 |
Las Vegas Sands
LVS
|
+$405M |
| 3 |
Qualcomm
QCOM
|
+$402M |
| 4 |
Warner Bros
WBD
|
+$400M |
| 5 |
Perrigo
PRGO
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.61% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Communication Services | 12.98% |
| 4 | Technology | 11.5% |
| 5 | Energy | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
RBC Bearings
RBC
$18.2B
| $3.56M | ﹤0.01% |
62,811
-826
| -1% | -$49.8K |
|
|
BCR
527
DELISTED
CR Bard Inc.
BCR
| $3.56M | ﹤0.01% |
+24,939
| New | +$3.68M |
|
|
KRFT
528
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $3.56M | ﹤0.01% |
63,049
+1,836
| +3% | +$106K |
|
529
Moog Inc Class A
MOG.A
$13.1B
| $3.55M | ﹤0.01% |
51,929
-3,348
| -6% | -$232K |
|
|
CSC
530
DELISTED
Computer Sciences
CSC
| $3.54M | ﹤0.01% |
+137,169
| New | +$3.53M |
|
|
VIAB
531
DELISTED
Viacom Inc. Class B
VIAB
| $3.51M | ﹤0.01% |
+45,667
| New | +$3.76M |
|
532
InspireMD
NSPR
$32.1M
| – | – |
0
| – | – |
|
533
Macy's
M
$6.62B
| $3.46M | ﹤0.01% |
59,475
-1,574
| -3% | -$93.3K |
|
|
TEN
534
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $3.42M | ﹤0.01% |
65,482
+318
| +0.5% | +$20.2K |
|
|
ADVM
535
DELISTED
Adverum Biotechnologies
ADVM
| $3.42M | ﹤0.01% |
+10,000
| New | +$2.98M |
|
|
FOMX
536
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.41M | ﹤0.01% |
+625,000
| New | +$3.59M |
|
537
Berkshire Hathaway Class B
BRK.B
$1.11T
| $3.38M | ﹤0.01% |
24,454
-543
| -2% | -$72.3K |
|
|
TEP
538
DELISTED
Tallgrass Energy Partners, LP
TEP
| $3.35M | ﹤0.01% |
+74,001
| New | +$3.13M |
|
539
Omeros
OMER
$816M
| $3.28M | ﹤0.01% |
257,896
-92,104
| -26% | -$1.29M |
|
540
Assembly Biosciences
ASMB
$507M
| $3.28M | ﹤0.01% |
33,333
| – | – |
|
541
Encompass Health
EHC
$11.5B
| $3.17M | ﹤0.01% |
108,042
-33,702
| -24% | -$1.03M |
|
542
BioCryst Pharmaceuticals
BCRX
$2.48B
| $3.14M | ﹤0.01% |
321,422
+480
| +0.1% | +$5.88K |
|
543
Invesco
IVZ
$13B
| $3.09M | ﹤0.01% |
+78,197
| New | +$3.08M |
|
544
Kohl's
KSS
$2.16B
| $3.08M | ﹤0.01% |
+50,385
| New | +$2.85M |
|
|
OMG
545
DELISTED
OM GROUP INC.
OMG
| $3.02M | ﹤0.01% |
116,546
+27,910
| +31% | +$785K |
|
|
RGP
546
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
| $2.92M | ﹤0.01% |
89,459
+42,156
| +89% | +$1.34M |
|
|
UTX.PRA
547
DELISTED
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
| $2.84M | ﹤0.01% |
48,297
-363,403
| -88% | -$22.2M |
|
548
Provident Financial Services
PFS
$3.15B
| $2.77M | ﹤0.01% |
169,535
+32,498
| +24% | +$549K |
|
549
DexCom
DXCM
$28.9B
| $2.75M | ﹤0.01% |
274,520
-7,952
| -3% | -$81.3K |
|
|
MGLN
550
DELISTED
Magellan Health Services, Inc.
MGLN
| $2.73M | ﹤0.01% |
49,975
-11,333
| -18% | -$650K |
|
Similar funds
Jennison Associates's Q3 2014 Portfolio in Review
As of Q3 2014, Jennison Associates held 788 positions worth $108B, down 0.96% from $109B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q3 2014 filing shows 82 new, 334 increased, 281 reduced and 71 closed positions. Its largest new stake was Alibaba: 9,140,584 shares worth $812M. The largest sale was RTX Corp, an estimated $839M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2014 buy was Alibaba: 9,140,584 shares worth $812M.
- Jennison Associates added most to Allergan plc in Q3 2014, an estimated $444M increase.
- Jennison Associates's biggest Q3 2014 reduction was Las Vegas Sands, cutting an estimated $405M.
- Jennison Associates fully exited RTX Corp in Q3 2014, selling an estimated $839M.
- Jennison Associates's ten largest holdings make up 20% of its $108B portfolio in Q3 2014.
- Jennison Associates opened 82 new positions and closed 71 in Q3 2014.
- Jennison Associates's portfolio value fell 0.96% quarter-over-quarter to $108B.
Based on Jennison Associates's 13F filing for Q3 2014, filed 5 Nov 2014.